Yazan Abou-Ismail/ LinkedIn
Jun 6, 2026, 23:30
Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared on LinkedIn:
”I had the opportunity to share some insights in this Medscape article on a snail-derived (Camaena cicatricose) compound being investigated as a potential novel anticoagulant with possibly improved bleeding profile.
So interesting!
Always great to see the landscape of thrombosis treatment evolve, and the interest in uncoupling thrombosis from hemostasis grow.
I weighed in on potential opportunities and some limitations.
Thank you Beth Rush for putting this together and including me!”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?